Pharsight

MITSUBISHI TANABE PHARMA PATENTS FACING OPPOSITIONS

Top patents of MITSUBISHI TANABE PHARMA facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2896397B2 06 Sep, 2017 Novel compounds having inhibitory activity against sodium-dependant glucose transporter NA 2
EP2252289B1 23 Oct, 2019 Combination therapy comprising sglt inhibitors and dpp4 inhibitors NA 1
EP2754440B1 03 Apr, 2019 Medicinal agent for treating amyotrophic lateral sclerosis or preventing progression of phase of amyotrophic lateral sclerosis Sep, 2032 1
EP1714960B1 28 Mar, 2018 Novel therapeutic agent for amyotrophic lateral sclerosis (als) or disease attributable to als Feb, 2025 1